Lecture 11 (Pulm)-Exam 6 Flashcards

1
Q

Acute bronchitis
* What is it?
* What are you exposed to?
* What is the infection aspect?⭐️

A

Inflammation and irritation of the large airway epithelium

Exposure to irritating environmental trigger (tobacco, allergen)

Infection
* MCC viruses (85 to 95%) – influenza, respiratory syncytial virus (RSV), parainfluenza (RIP)
* Bacteria (5%) – M. pneumoniae, C. pneumoniae, Bordetella pertussis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the sxs of acute bronchitis?

A

Cough persisting for > 5 days
* Other symptoms (dyspnea, cyanosis, airway obstruction) rare
* ± fever
* ± transient wheezing or crackles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acute Bronchitis
* How do you dx it?
* What is not recommended?⭐️

A
  • Diagnosis – clinical; CXR only if diagnosis unsure
  • Sputum cultures not recommended
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acute bronchitis
* What is the txt?
* Cough cont for how long?
* What does the patient need adequate of?
* What over the OTC meds that can be used?
* What should be avoided?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the nonpharm cough agents for bronchitis?

A
  • Lozenges
  • Hot tea (± honey)
  • Smoking cessation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BRONCHITIS – COUGH AGENTS
* What are all 4 of them?

A
  • Dextromethorphan
  • Benzonatate
  • Codeine/hydrocodone
  • Guaifenesin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dextromethorphan
* What is the MOA?
* What are the adverse reaction?

A

MOA
* Depresses the medullary cough centers
* Decreases sensitivity of cough receptors and interrupts cough impulse transmission

SE:
* Nausea, vomiting
* Dizziness
* Drowsiness
* Hyperpyretic crisis with MAOIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Benzonatate:
* What is the MOA
* What are the adverse reactions?

A

MOA
* Suppresses cough by topical anesthetic action on pulmonary stretch receptors in alveoli

Adverse Effects
* Dizziness
* Drowsiness
* Dysphagia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Codeine/hydrocodone
* What is the MOA?
* What are the adverse reactions?

A

MOA:
* Mu receptor antagonism; central suppression of cough center

Adverse reactions:
* Sedation
* Nausea /vomiting /constipation
* Respiratory depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Guaifenesin:
* What do you take with?
* What is the MOA?
* What are the se?

A
  • Take with plenty of water
  • Stimulates the flow of respiratory secretions; decreases viscosity and increases quanity of respiratory secretions-> EASIER to cough out
  • SE: N/V, dizziness, drowsiness and HA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ANTI-INFLUENZA AGENTS
* What is the MOA of amantadine?
* What is the MOA of xofluza?
* What is the MOA of NA inhibitors?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ANTI-INFLUENZA AGENTS: Amantadine(PO) & Rimantadine (PO)
* What is the class and MOA
* What is the spectrum?
* What are the SE?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ANTI-INFLUENZA AGENTS: Oseltamivir & Zanamivr
* What is the class MOA?
* What is the spectrum?
* What are the SE?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ANTI-INFLUENZA AGENTS: Baloxavir marboxil
* What is the class MOA?
* What is the spectrum?
* What are the SE?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What anti-influ drug is approved for all age groups included pregnant women?

A

Neuraminidase inhibitors MC
* Oseltamivir MC – approved for all age groups including pregnant woman
* Oral tablets and suspension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anti influenza agents:
* What groups need treatment and post-exposure prophylaxis?

A
  • Chronic lung disease (COPD, asthma)
  • Organ dysfunction (heart, kidney, liver)
  • Neurologic disorders
  • Immunocompromised
  • Obese
  • Extremes of age (> 65 years or < 2 years)
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ANTI-INFLUENZA AGENTS
* Treatment must be started within what window?
* Hospitalized patients may benefit if started within what time frame?
* What is the point of txt?

A
  • Treatment must start within 48 hours of symptoms onset – modest symptom reduction in healthy patients
  • Hospitalized patients may benefit if started within 5 days of symptom onset
  • Decrease in duration of symptoms (avg: 1 day) and severity of disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Seasonal flu vaccine recommended for who?

A

all patients without vaccine contraindications > 6 months of age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Community-acquired Pneumonia (CAP)
* When does it occur?
* What are the two classes?

A

Occurs in the community or within first 48 hrs of hospitalization

May be typical or atypical
* Typical ”classic” Presentation: Chills, followed by fever, pleuritic pain and productive cough
* Atypical Presentation: (Often associated with Mycoplasma, Chlamydia or Legionella infection) Sore throat & Headache, followed by NON-productive cough and dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nosocomial pneumonia (VAP +/- MDR & HAP)
* When does this occur?
* What are the MC bacterial pathogens?
* What is common?

A
  • Occurs during hospitalization after first 72 hours
  • MC bacterial pathogens are gram-negative rods (E. coli, Pseudomonas) and Staphylococcus aureus
  • Multidrug resistant (MDR) pathogens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the two methods of prevention of pneumonia?

A

Influenza vaccine (yearly)

Pneumococcal vaccine (>65 years and any high-risk any patients)
* High risk: [heart disease, sickle cell, pulmonary disease, diabetes, alcoholic cirrhosis or asplenic individuals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MICROBIOLOGY OF CAP
* What are the pathogens for typical?
* What are the pathogens for atypical?
* What are some other organisms?

A

Typical:
* Streptococcus pneumoniae
* Hemophilus influenzae
* Staphylococcus aureus

Atypical:
* Mycoplasma pneumoniae
* Chlamydophila pneumoniae
* Legionella pneumoniae (high mortality)-> Up to 40% of CAP cases & Often undetected due to poor diagnostic tools

Other:
* Respiratory viruses – Influenza
* Aspiration – associated oral flora
* Gram-negative bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Fill in for CAP by age

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What do you need to diagnosis CAP in 18+ without immunocompromising conditions?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What do you need to diagnosis severe CAP ?
26
What is the curb 65?
27
What is the empirical txt for CAP outpt with someone who has no comorbdities or risk factors?
28
What is the empirical txt for CAP outpt with someone who has comorbdities?
29
CAP outpt txt key points * Selection is made based on patient? * how long is the treatment for? * What do you want for the patient after txt (3)? * What are the SE of macrolides? * What is the DOC of atypicals? * What is the issue with fluroquinolones?
30
HOSPITALIZED PATIENT - NON-SEVERE CAP TXT
31
HOSPITALIZED PATIENT - SEVERE CAP TXT
32
What are the cell wall active agents?
## Footnote Please, Come Cee My Vechial, I Hit Wall
33
34
35
36
37
Skip 3rd gen because it has a separate card
38
CARBAPENEMS * What are the four meds? * What is the MOA? * What makes them different?
* Imipenem, meropenem, ertapenem, doripenem (IV only) * MOA: inhibit bacterial cell wall synthesis * Still have beta-lactam ring but slight structure change including substitution from sulfur with carbon makes them more resistant to beta lactamases
39
CARBAPENEMS * Narrow or broad spectrum? * Which drug does not cover pseduomonas or acinetobacter? * What is doripenem for? * Should be reserved for what?
40
CARBAPENEMS * What are the SE?
* ­Nausea / vomiting (worse with imipenem) * Seizures (worse with imipenem)
41
VANCOMYCIN * What is the MOA?
MOA: inhibits bacterial wall synthesis Glycopeptide antibiotic – binds tetrapeptide chains and prevents linking * Do not bind PBPs – bypass PBP mutations * Resistance secondary to bacterial changes in the tetrapeptide chains – vancomycin can no longer bind
42
What are the indications of vancomycin?
* Treatment of gram-positive organisms resistant to other antibiotics * Commonly incorporated into empiric regimens * Treatment of Clostridium difficile enterocolitis
43
Vancomycin must be given how? Why?
Not absorbed from the GI tract – must be given IV for systemic infections
44
What are the SE of Vancomycin?
* ­ Ototoxicity * ­ Nephrotoxicity * ­ Thrombophlebitis * ­ “Red-man’s syndrome
45
Dose and frequency of vancomycin is determined and monitored via what?
* Troughs – adjust per clinical pharmacy * Goal trough levels usually 15 to 20; depends on infection and MIC of bacteria
46
TETRACYCLINES * What are the different meds? * What is the MOA?
Tetracycline, doxycycline, minocycline, tigecycline MOA: inhibit bacterial protein synthesis * Binds to A-site of 30S subunit * Inhibits binding of tRNA to mRNA ribosome complex
47
Tetracylines: * What do they cover? * What is no longer used and why?
48
49
TETRACYCLINES * What are the SE?(7)
50
Macrolides: * What are the different meds? * What is the MOA?
Erythromycin, clarithromycin, azithromycin MOA * ­ Inhibits bacterial protein synthesis * ­ Bind to 50s subunit and prevent translocation; ribosome can’t slide to the next codon on the mRNA
51
Macrolides: * What is the coverage? * What is less often used and why?
52
53
MACROLIDES * What are the Interactions? * What are the SE?
54
Fluoroquinolones: * What are the different types? * What is the MOA? * How is it metabolized?
* Ciprofloxacin, levofloxacin, moxifloxacin, delafloxacin * MOA: Inhibits bacterial replication by inhibition of DNA gyrase (topoisomerase I and topoisomerase IV) * Metabolized via CYP450; also inhibitor ->Many drug interactions
55
FLUOROQUINOLONES * Should not be taken with what?
Should not be taken with calcium, iron, zinc – bind quinolones and cause chelation and decreased absorption
56
What are the SE of fluoroquinolones?(6)
57
58
59
What are the black box warnings about fluoroquinolones?
* Serious, potentially irreversible adverse effects including tendinopathy and CNS effects. Avoid use / discontinue in any patients experiencing these side effects. * Risks > benefits for chronic bronchitis, sinusitis, uncomplicated cystitis
60
When should you switch from IV to PO?
61
HAP AND VAP * What are they?
Hospital Acquired Pneumonia (HAP) * Pneumonia that occurs ≥ 48 hours after admission; not incubating at admission Ventilator Associated Pneumonia (VAP) * Type of HAP that develops after endotracheal intubation
62
What are the most common causes of HAP and VAP?
63
HAP AND VAP EMPIRIC THERAPY * Treatment should be what? * What do you need to be worried about? * What is the minimum duration of therapy? * May do what?
64
65
HAP and VAP empiric therapy: * What is the txt of a patient who is not high risk of mortality and not at high risk of MRSA?(5)
## Footnote MC LAP
66
HAP and VAP empiric txt: * What is the txt of a patient who is not high risk of morality and high risk of MRSA
67
68
69
70
71
Fill in for MOA
inhibition of fungal agents and cell wall synthesis
72
73
74
* What is first line for Histoplasmosis (mild and severe? * What are the alternatives? * What is the txt duration?
75
* What is first line for Blastomyosis (mild and severe? * What are the alternatives? * What is the txt duration?
76
* What is first line for Coccidiomyosis (mild and severe? * What are the alternatives? * What is the txt duration?
77
Pneumocystis jirovecii * What type of patients do you see this in? * What does the CXR look like?
* HIV/AIDS with CD4 < 200 cells/mm3 * Solid organ and bone marrow transplant patients * Cancer chemotherapy patients * Most require primary chemoprophylaxis with TMP-SMX, pentamidine ## Footnote O2 will be lower than how bad the Xray looks
78
Pneumocystis jirovecii * What is the txt?
TMP/SMX x 21 days (PO or IV) * Prednisone (first dose prior to starting anti-PJP therapy) * 40mg PO BID x 5d, 40mg PO daily x 5d, then 20mg PO daily x 11 days
79
Sulfamethoxazole / trimethoprim (SMX/TMp) * What is the MOA? * What is the dosing based on * What is the one double strength tablet? * What can there be an allergic reaction to?
* MOA: inhibit bacterial DNA synthesis; each inhibit different steps in bacterial folate synthesis; no folate = no nucleic acids = no DNA * Dosing based on TMP component * One double strength tablet = 160 mg TMP/ 800mg SMX * Allergic reaction to sulfonamide group: can cross react with other drugs with sulfonamide group including hydrochlorothiazide and glyburide
80
Sulfamethoxazole / trimethoprim (SMX/TMp) * What are the CI? * What type of inhibitor is it?
* CI: pregnancy, infants < 2 months * CYP450 2C9 inhibitor - increases warfarin levels
81
Sulfamethoxazole / trimethoprim * What are the SE?(6)
82
83
Tuberculosis txt * When a patient has a latent TB what test is positive? * What is the txt?
84
Fill in for TB test
85
Tuberculosis treatment * What is the txt for active disease? * HIV patients shuold get no less than what?
86
When will TB treatment change?
* Regimen will change for multi-drug resistant TB
87
88
Anti-TB medicaiton
89
90
91
* Which anti-TB medications are hepatotoxic? What drugs' * MOA is inhibiting Cell wall?
* Liver:Pyrazinamide, Isoniazid, Rifampin * Cell wall:Isoniazid, Pyrazinamide and ethambutol
92
Acute bronchiolitis * What is this? * What are the inital symptoms? What does that turn into? * What is the MCC cause? * What is recommended for mild disease? * What is the recommended for patients with severe disease?
93
ACUTE BRONCHIOLITIS * What is the pathophysio?
* Viruses replicate in the nasopharynx * Infects the small bronchiolar epithelium * Extends to the type 1 and 2 alveolar pneumocytes * Lower respiratory tract infection 1-3 days later * mucus buildup, airway obstruction, air trapping, and increased airway resistance
94
Outpatient treatment: Acute bronchiolitis * What is the supportive care?
Hydration Relieve nasal congestion / obstruction Anticipatory guidance * Clinical course (onset, peak-> 3-5days, resolution) * Evaluation for worsening disease (retractions, dry diapers, no tears, dipping fontelles) * Indications to seek urgent medical care * Use of nasal decongestants, bronchodilators is NOT recommended
95
How do you use a nasal bulb suction?
96
Acute bronchiolitis * What are the indications for hospitalization?
* Toxic appearing * Lethargic * Dehydrated * Poor feeding * Moderate respiratory distress * Nasal flaring, retractions, grunting * **RR > 70 bpm** * **O2 < 95% sustained** * **Apnea**
97
What is the inpatient treatment for Acute bronchiolitis?
98
What is no recommended for inpatient treatment of Acute bronchiolitis?
* Routine use of beta-2 agonists (SABAs) not recommended * Routine use of inhaled racemic epinephrine or hypertonic saline is not recommended * Routine use of glucocorticoids not recommended * Routine use of antivirals (ribavirin) not recommended
99
Palivizumab (synagis) * What is it? * What does it decrease? * What are the MC populations recommoned this? * Limited by what?
100
EPIGLOTTITIS: What is it?
inflammation of the epiglottis and adjacent supraglottic structures, potentially life- threatening condition
101
What do you see on x-ray with epiglottitis?
* Imaging: lateral neck xray * “Thumbprint Sign”
102
What are the inital interventions of epiglottitis?
* Airway management – keep airway open * AVOID irritation
103
What are the MC organisms for epiglottitis?
104
What is the first line txt of epiglottitis? What if the patient is penicillin allergic?
105
CROUP- VIRAL * What is the pathophysio? * What is the mc organism?
* Pathophysiology – infection → inflammation of larynx, trachea, bronchi, bronchioles and lung parenchyma resulting in swelling and exudate, anatomic hallmark is narrowing of the subglottic airway * Organism: Parainfluenza
106
What is the x-ray sign in croup?
107
What are the symptoms of mild croup?
* No stridor at rest * Stridor when agitated * Barking cough * Hoarse cry * Mild to no retractions
108
What is the txt of Mild croup?
* Humidified air * Antipyretics * Hydration * Anticipatory guidance * Steroids * Dexamethasone 0.6 mg/kg PO x 1 dose * Budesonide 2 mg via nebulizer x 1 dose ## Footnote Dexamethasone reduces repeat clinic visits, emergency department visits, or hospitalizations
109
What are the symptoms of moderate croup?
* Stridor at rest * Mild retractions * ± other signs of respiratory distress * Little to no agitation
110
What are the symptoms of severe croup?
* Stridor at rest * Severe retractions * Anxious, agitated, fatigued
111
What is the txt for mod to severe croup? (good response, Good response with worsening during observation and Poor response)
112
Racemic epinephrine * What is it? * MOA in croup?
1:1 mixture of levo and dextro epinephrine MOA in croup: * Alpha-1 stimulation – vasoconstriction, reduce tissue edema * Beta-1 stimulation – vasoconstriction in skin and mucosa
113
Racemic epinephrine * What is uncommon? * **What may occur?** * What is the dose?
114
Pertussis – “Whooping Cough” * What is the organism? * When is increased incidence? * How is it transmitted? * How does it cycle in the US?
* Etiology – gram-negative coccobacillus – Bordetella pertussis * Increased incidence summer and fall * Transmission via respiratory droplets * In US it cycles q3-5yrs – the incidence of pertussis has been rising since the 1990s (increased rates of infection in adolescents and adults)
115
* What is the prevent against pertussis? * What are the dosing ages?
116
What is Dtap? * Who do you give it to?
117
What is Tdap? * Who do you give it to?
118
Pertussis: * What is the Catarrhal stage?
Catarrhal (1-2 weeks): treatment started at this phase can shorten disease course
119
Pertussis: * What is the Paroxysomal stage?
Paroxysmal (2 to 4 weeks): treatment has little effect on disease course but can eradicate nasal carriage and prevent disease spread
120
What is the concalscence stage?
Convalescence (1-2 weeks): Patient still infectious; treat to eradicate carriage state
121
PERTUSSIS TREATMENT * When do you tx if over a year old? * When do you tx if infant < 1 year or pregnant woman,
* ­ If over 1 year of age, treat if within 3 weeks of cough onset * ­ If infant < 1 year or pregnant woman, treat if within 6 weeks of cough onset
122
PERTUSSIS TREATMENT * What is the supportive care? * When can patients return to school and work
123
What are the three meds for pertussis?
* Azithromycin (PO or IV) * Erythromycin (cannot use under one month) * Clarithromycin (cannot use under one month)
124
Pertussis treatment * What is the post exposure prophylaxis?
* Household contacts * Others exposed within 21 days at high-risk of severe disease * Pregnant women, infants < 1-year, immunosuppressed, chronic lung disease, respiratory insufficiency, cystic fibrosis, persons who have close contact with infants
125
Cystic Fibrosis * What is the pathophyio
Affects nearly all exocrine glands = abnormal transport of chloride and sodium across secretory epithelia →thickened, viscous secretions in the bronchi, biliary tract, pancreas, intestines, and reproductive system
126
What is cysstic fibrosis the leading cause of?
A leading cause of bronchiectasis
127
Cystic Fibrosis: bacterial * Lungs are what? * What are the bacteria in infants and children? * What is the bacteria for all ages? * What is going with MRSA, Mycobacterium avium complex & M. abscessus
128
CF managment: * What meds are there depending on genotype and age? * What are airway clearance therapies? * What are the prevention measures? * What are the bronchodilators? * What is the anti-inflam therapy? * What is the prevention of acute exacerbations?
129
130
RESPIRATORY DISTRESS SYNDROME (HYALINE MEMBRANE DISEASE) * What is the definition? * When does surfactant begin production? * What is the type 2 pneumocytes?
131
Respiratory Distress Syndrome(Hyaline Membrane Disease) * What is the pathophysio?
* Inadequate surfactant activity →high surface tension →instability of the lung at end-expiration→ low lung volume & decreased compliance * Surfactant deficiency → lung inflammation & respiratory epithelial injury→ increased airway resistance & possible pulmonary edema
132
Respiratory Distress Syndrome(Hyaline Membrane Disease) * What is the txt?
* Treatment includes intratracheal surfactant therapy, supplemental O2 & mechanical ventilation as needed * Survival rate >90% with treatment
133
Respiratory Distress Syndrome(Hyaline Membrane Disease) * What is the prevention?